✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
We present the case of a 2-year-old child with abdominopelvic rhabdomyosarcoma undergoing CRS-HIPEC and discuss the perioperative concerns and challenges.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a well-established multimodal treatment in patients with peritoneal surface malignancies in adults.
📊
Key Findings & Data:Children younger than 3 years rarely undergo such extensive surgeries with heated chemotherapy infusion intraoperatively.
💡
Conclusion & Impact:We present the case of a 2-year-old child with abdominopelvic rhabdomyosarcoma undergoing CRS-HIPEC and discuss the perioperative concerns and challenges.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a well-established multimodal treatment in patients with peritoneal surface malignancies in adults. Children younger than 3 years rarely undergo such extensive surgeries with heated chemotherapy infusion intraoperatively. Only one such case is reported in the literature for CRS-HIPEC for an abdominopelvic rhabdomyosarcoma in a child of 2 years or less. We present the case of a 2-year-old child with abdominopelvic rhabdomyosarcoma undergoing CRS-HIPEC and discuss the perioperative concerns and challenges.
🔖
Cite This Article
DOCTOR, J. R., SOLANKI, S. L., JAIN, A. R., PATIL, V. P. (2022). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a 2-Year- Old Child with Abdominopelvic Rhabdomyosarcoma: A Case Report of Anaesthetic Concerns. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 50 - Sayı: 1, 68–71. https://ajindex.com/articles/414173